Fri, May 24, 2013, 7:10 AM EDT - U.S. Markets open in 2 hrs 20 mins
Not sure what you are hoping he is right about. Maybe I missed it, wouldn't be the first time. I guess that if Pfizer continues to fail at targeted cancer drugs, we can hope that they see more value in Ziopharm.
sorry, I was referring to this:Lewis says that some big drug companies are starting to consider going back to working on safer versions of toxic chemotherapy, an approach his small company is championing.